RAPID: Structural investigation of interactors of SARS CoV 2

  • Funded by National Science Foundation (NSF)
  • Total publications:2 publications

Grant number: 2031205

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $200,000
  • Funder

    National Science Foundation (NSF)
  • Principal Investigator

    James Fraser
  • Research Location

    United States of America
  • Lead Research Institution

    University of California-San Francisco
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Biological Sciences - The SARS-COV-2 virus genome encodes a very small set of proteins. Having such a minimal genome means that the virus relies on host factors to complete its infectious cycle. Researchers supported by this award will investigate the mechanisms by which interactions between viral and host cell proteins might antagonize innate immune defenses and lead to increased virulence. Elucidating the structural basis for how SARS-COV-2 hijacks and disrupts host cellular processes may aid in the development of host-directed therapies as a means to combat epidemics and will provide new insight into how genetic variation of host proteins can influences differences in infection severity and spread between populations and species. Data and resources from these studies will be rapidly disseminated through public WWW-sites, social media, shared data repositories, and published in peer-reviewed scientific journals.

Protein regions that are structurally dynamic upon changing the data collection temperature are highly correlated with small molecule binding sites. Studies supported by this award will test the hypothesis that the regions of viral and host proteins that are most structurally susceptible to temperature perturbation, detectable by multi-temperature synchrotron and x-ray free electron laser (XFEL) experiments, are likely to represent the footprints of protein-protein interactions and to bind small molecule ligands. The researchers will use an innovative combination of multi-temperature X-ray data collection of individual proteins at synchrotrons and XFELs, high throughput crystal fragment screening, and structure determination of viral-human complexes. Results from these studies will advance the understanding of SARS-COV-2 biology and may also yield more generalizable insights into mechanisms of virulence. This RAPID award to the University of California-San Francisco is made by the Division of Biological Infrastructure using funds from the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Publicationslinked via Europe PMC

Last Updated:14 hours ago

View all publications at Europe PMC

Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2.

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.